Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00538304 · ClinicalTrials.gov registry record · Phase 2
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 222
- Enrollment target
NCT00538304 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 222 participants.
The verdict
NCT00538304, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 222 participants
- Enrollment target
Study Summary
A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
Interventions
- DRUG placebo
- DRUG bimatoprost eye drops
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00538304
The ClinicalTrials.gov registry entry for NCT00538304 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00538304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00538304 about?
NCT00538304 is a clinical study titled "A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension". A one month study which will determine the safety and efficacy of bimatoprost eye drops in patients with glaucoma or ocular hypertension
What is the current status of trial NCT00538304?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 222 participants. The study started on 2007-11. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00538304?
The interventions under investigation include: placebo (DRUG), bimatoprost eye drops (DRUG).
Who is sponsoring clinical trial NCT00538304?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.